Advanced Technologies - National Center for Image Guided Therapy (AT-NCIGT)
Project Number5P41EB028741-02
Contact PI/Project LeaderTEMPANY, CLARE M
Awardee OrganizationBRIGHAM AND WOMEN'S HOSPITAL
Description
Abstract Text
ABSTRACT: The intersection of healthcare and biomedical research is at an inflection point with the
convergence of the digital revolution, advances in imaging, nanotechnology, big data science, and
precision or personalized medicine. There is a wealth of meaningful, but complex information that could
be extracted from imaging data but is not optimally utilized for patient care. Cancer care exemplifies the
current challenges which include early detection, accurate distinction of pre- neoplastic and neoplastic
lesions, prediction of tumor aggressiveness, determining infiltrative tumor margins during surgical
treatment, tracking tumor evolution/ metastasis pattern, recurrence, and potential acquired resistance to
treatments over time. Major strides have been made in the personalization of cancer therapies such as
immunotherapy, but the availability of specific, relevant, and timely medical data and information is of
critical importance to realizing the full potential of precision medicine. Nowhere is this more acutely
evident than during interventions in the operating and procedure rooms. Novel methods of image
guidance, data integration, information extraction, and knowledge transfer are needed to enable
clinicians to fully leverage the information available, especially before, during and after invasive
procedures. We are excited to re-submit a proposal for a new P41 biomedical resource center (BTRC)
called Advanced Technologies for NCIGT(AT-NCIGT) with 3 TRDs, 10 new collaborative and 10 new
service projects, all of which aim to investigate develop and disseminate new technologies for image
guided therapy (IGT). The 3 components are Imaging Cancer Heterogeneity for IGT, Deep Learning
for IGT and Intraoperative devices for IGT. These new technologies alone and in combinations will
allow for greater understanding of disease state, treatment guidance, integration/navigation and in-vivo
monitoring of tissue responses and improve the precision of invasive procedures.
Thus the overall goal of this proposal is to investigate, develop and disseminate novel technologies for
extracting new tissue characteristics (technology research and development core TRD 1: Imaging cancer
heterogeneity; analyze them and make them available through state-of-the-art algorithmic and data
curation approaches (Deep Learning TRD 2); and enable precise tissue sampling surgical navigation and
in-vivo tissue response through the results of novel Intraoperative devices (Intraoperative devices for
IGT: TRD 3). In order to effectively disseminate all this new knowledge we have 10 new collaborative and
10 new service projects and will share these novel tools through our established mechanisms, from
current BTRC- National Center for Image Guided Therapy (NCIGT), which continues to be dedicated to
the innovating for IGT into interventional radiology, surgery, radiation oncology, and procedure-based
medicine.
Public Health Relevance Statement
Project Narrative
The Advanced Technologies-National Center for Image guided Therapy (AT-NCIGT) is a
research and technology center with the mission of advancing patient care, by developing novel
innovative tools for image guided Therapy (IGT). The three technologies encompass Imaging
Cancer Heterogeneity, Deep learning and Intraoperative devices for image guided therapy
which will be investigated both individually and in cross TR &D combinations. We will
disseminate all technologies through a national network of collaborators, making these
discoveries available to the larger medical community.
NIH Spending Category
No NIH Spending Category available.
Project Terms
3-DimensionalAcuteAlgorithmsArchitectureAtlas of Cancer Mortality in the United StatesAugmented RealityBiomedical ResearchBiopsy SpecimenBloodBrainBrain NeoplasmsCellsCharacteristicsCommunitiesComplexComputer Vision SystemsComputer softwareConventional SurgeryDataDevelopmentDevicesDiffusionDisciplineDiseaseEarly DiagnosisEffectivenessEvolutionFoundationsGoalsHealth Care ResearchHeterogeneityHistopathologyImageImaging DeviceImaging TechniquesImmunotherapyIndividualInformation RetrievalInfrastructureInterventionInterventional radiologyKnowledgeLesionLongitudinal StudiesLungMagnetic ResonanceMagnetic Resonance ImagingMalignant neoplasm of prostateMedicalMedicineMetabolic MarkerMetabolismMetadataMethodsMicroscopicMissionModelingMolecularMorphologyNanotechnologyNavigation SystemNeedlesNeoplasm MetastasisOperating RoomsOperative Surgical ProceduresPatient CarePatient-Focused OutcomesPatternPhysiologic pulseProceduresProstateRadiation OncologyRecurrenceResearchResistanceResolutionRetrievalRisk AssessmentSamplingServicesSignal TransductionSourceSpecimenSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSpeedSupervisionT2 weighted imagingTechnologyTestingTimeTissue SampleTissue imagingTissuesVisualizationbasebig-data sciencebiomedical resourcebrain surgerycancer carecancer heterogeneitycancer imagingcancer therapydata curationdata integrationdeep learningdesigndigitalimage guidedimage guided therapyimage registrationimaging facilitiesimaging modalityimprovedin vivoin vivo monitoringinnovationion mobilitylearning strategymachine learning algorithmmass spectrometermass spectrometric imagingmetabolic imagingmicrodeviceneoplasticnew technologynovelnovel strategiesovertreatmentpersonalized cancer therapypersonalized medicineprecision medicineprostate biopsyprotocol developmentresponsesurgery outcometechnology research and developmenttissue oxygenationtooltraittumortumor heterogeneitytumor hypoxia
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
030811269
UEI
QN6MS4VN7BD1
Project Start Date
06-January-2021
Project End Date
31-December-2025
Budget Start Date
01-January-2022
Budget End Date
31-December-2022
Project Funding Information for 2022
Total Funding
$1,391,424
Direct Costs
$798,924
Indirect Costs
$592,500
Year
Funding IC
FY Total Cost by IC
2022
National Institute of Biomedical Imaging and Bioengineering
$1,391,424
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P41EB028741-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P41EB028741-02
Patents
No Patents information available for 5P41EB028741-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P41EB028741-02
Clinical Studies
No Clinical Studies information available for 5P41EB028741-02
News and More
Related News Releases
No news release information available for 5P41EB028741-02
History
No Historical information available for 5P41EB028741-02
Similar Projects
No Similar Projects information available for 5P41EB028741-02